Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects

The concept of spatial fractionation in radiotherapy was developed for better sparing of normal tissue in the entrance channel of radiation. Spatial fractionation utilizing proton minibeam radiotherapy (pMBRT) promises to be advantageous compared to X-ray minibeams due to higher dose conformity at t...

Full description

Bibliographic Details
Main Authors: Gerd Datzmann, Matthias Sammer, Stefanie Girst, Michael Mayerhofer, Günther Dollinger, Judith Reindl
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Physics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphy.2020.568206/full
_version_ 1818857514585817088
author Gerd Datzmann
Gerd Datzmann
Matthias Sammer
Stefanie Girst
Michael Mayerhofer
Günther Dollinger
Judith Reindl
author_facet Gerd Datzmann
Gerd Datzmann
Matthias Sammer
Stefanie Girst
Michael Mayerhofer
Günther Dollinger
Judith Reindl
author_sort Gerd Datzmann
collection DOAJ
description The concept of spatial fractionation in radiotherapy was developed for better sparing of normal tissue in the entrance channel of radiation. Spatial fractionation utilizing proton minibeam radiotherapy (pMBRT) promises to be advantageous compared to X-ray minibeams due to higher dose conformity at the tumor. Preclinical in vivo experiments conducted with pMBRT in mouse ear models or in rat brains support the prospects, but the research about the radiobiological mechanisms and the search for adequate application parameters delivering the most beneficial minibeam therapy is still in its infancy. Concerning preclinical research, we consider glioma, non-small cell lung cancer and hepatocellular carcinoma as the most promising targets and propose investigating the effects on healthy tissue, especially neuronal cells and abdominal organs. The experimental setups for preclinical pMBRT used so far follow different technological approaches, and experience technical limitations when addressing the current questions in the field. We review the crucial physics parameters necessary for proton minibeam production and link them to the technological challenges to be solved for providing an optimal research environment. We consider focusing of pencil or planar minibeams in a scanning approach superior compared to collimation due to less beam halos, higher peak-to-valley dose ratios and higher achievable dose rates. A possible solution to serve such a focusing system with a high-quality proton beam at all relevant energies is identified to be a 3 GHz radio-frequency linear accelerator. We propose using a 16 MeV proton beam from an existing tandem accelerator injected into a linear post-accelerator, boosted up to 70 MeV, and finally delivered to an imaging and positioning end-station suitable for small animal irradiation. Ion-optical simulations show that this combination can generate focused proton minibeams with sizes down to 0.1 mm at 18 nA mean proton current - sufficient for all relevant preclinical experiments. This technology is expected to offer powerful and versatile tools for unleashing structured and advanced preclinical pMBRT studies at the limits and also has the potential to enable a next step into precision tumor therapy.
first_indexed 2024-12-19T08:41:36Z
format Article
id doaj.art-2fbacee4363b482584a7e545ac59a847
institution Directory Open Access Journal
issn 2296-424X
language English
last_indexed 2024-12-19T08:41:36Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physics
spelling doaj.art-2fbacee4363b482584a7e545ac59a8472022-12-21T20:28:56ZengFrontiers Media S.A.Frontiers in Physics2296-424X2020-11-01810.3389/fphy.2020.568206568206Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical AspectsGerd Datzmann0Gerd Datzmann1Matthias Sammer2Stefanie Girst3Michael Mayerhofer4Günther Dollinger5Judith Reindl6Institut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, Neubiberg, GermanyDatzmann Interact & Innovate GmbH, Munich, GermanyInstitut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, Neubiberg, GermanyInstitut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, Neubiberg, GermanyInstitut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, Neubiberg, GermanyInstitut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, Neubiberg, GermanyInstitut für Angewandte Physik und Messtechnik (LRT2), Universität der Bundeswehr München, Neubiberg, GermanyThe concept of spatial fractionation in radiotherapy was developed for better sparing of normal tissue in the entrance channel of radiation. Spatial fractionation utilizing proton minibeam radiotherapy (pMBRT) promises to be advantageous compared to X-ray minibeams due to higher dose conformity at the tumor. Preclinical in vivo experiments conducted with pMBRT in mouse ear models or in rat brains support the prospects, but the research about the radiobiological mechanisms and the search for adequate application parameters delivering the most beneficial minibeam therapy is still in its infancy. Concerning preclinical research, we consider glioma, non-small cell lung cancer and hepatocellular carcinoma as the most promising targets and propose investigating the effects on healthy tissue, especially neuronal cells and abdominal organs. The experimental setups for preclinical pMBRT used so far follow different technological approaches, and experience technical limitations when addressing the current questions in the field. We review the crucial physics parameters necessary for proton minibeam production and link them to the technological challenges to be solved for providing an optimal research environment. We consider focusing of pencil or planar minibeams in a scanning approach superior compared to collimation due to less beam halos, higher peak-to-valley dose ratios and higher achievable dose rates. A possible solution to serve such a focusing system with a high-quality proton beam at all relevant energies is identified to be a 3 GHz radio-frequency linear accelerator. We propose using a 16 MeV proton beam from an existing tandem accelerator injected into a linear post-accelerator, boosted up to 70 MeV, and finally delivered to an imaging and positioning end-station suitable for small animal irradiation. Ion-optical simulations show that this combination can generate focused proton minibeams with sizes down to 0.1 mm at 18 nA mean proton current - sufficient for all relevant preclinical experiments. This technology is expected to offer powerful and versatile tools for unleashing structured and advanced preclinical pMBRT studies at the limits and also has the potential to enable a next step into precision tumor therapy.https://www.frontiersin.org/articles/10.3389/fphy.2020.568206/fullproton minibeam radio therapyspatial fractionationlinear acceleratorpreclinicirradiation facilitypencil beam scanning
spellingShingle Gerd Datzmann
Gerd Datzmann
Matthias Sammer
Stefanie Girst
Michael Mayerhofer
Günther Dollinger
Judith Reindl
Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
Frontiers in Physics
proton minibeam radio therapy
spatial fractionation
linear accelerator
preclinic
irradiation facility
pencil beam scanning
title Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
title_full Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
title_fullStr Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
title_full_unstemmed Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
title_short Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
title_sort preclinical challenges in proton minibeam radiotherapy physics and biomedical aspects
topic proton minibeam radio therapy
spatial fractionation
linear accelerator
preclinic
irradiation facility
pencil beam scanning
url https://www.frontiersin.org/articles/10.3389/fphy.2020.568206/full
work_keys_str_mv AT gerddatzmann preclinicalchallengesinprotonminibeamradiotherapyphysicsandbiomedicalaspects
AT gerddatzmann preclinicalchallengesinprotonminibeamradiotherapyphysicsandbiomedicalaspects
AT matthiassammer preclinicalchallengesinprotonminibeamradiotherapyphysicsandbiomedicalaspects
AT stefaniegirst preclinicalchallengesinprotonminibeamradiotherapyphysicsandbiomedicalaspects
AT michaelmayerhofer preclinicalchallengesinprotonminibeamradiotherapyphysicsandbiomedicalaspects
AT guntherdollinger preclinicalchallengesinprotonminibeamradiotherapyphysicsandbiomedicalaspects
AT judithreindl preclinicalchallengesinprotonminibeamradiotherapyphysicsandbiomedicalaspects